Busulfan (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Busulfan drug offered from Sagent Pharmaceuticals. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: Busulfan
SUBSTANCE NAME: BUSULFAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-05-15
END MARKETING DATE: 0000-00-00


Busulfan HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBusulfan from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/mL)
START MARKETING DATE: 2017-05-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-241_fb195d4c-7f7e-442a-b9b6-a51cc7796e00
PRODUCT NDC: 25021-241
APPLICATION NUMBER: ANDA207050

Other BUSULFAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.N/A
Aspen Global Inc.MYLERAN
Otsuka America Pharmaceutical, Inc.BUSULFEX
Pharmascience Inc.Busulfan
Sagent PharmaceuticalsBusulfan